BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 20190467)

  • 21. Low serum levels of undercarboxylated osteocalcin in postmenopausal osteoporotic women receiving an inhibitor of bone resorption.
    Aonuma H; Miyakoshi N; Hongo M; Kasukawa Y; Shimada Y
    Tohoku J Exp Med; 2009 Jul; 218(3):201-5. PubMed ID: 19561390
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The effects of vitamin K-rich green leafy vegetables on bone metabolism: A 4-week randomised controlled trial in middle-aged and older individuals.
    Sim M; Lewis JR; Prince RL; Levinger I; Brennan-Speranza TC; Palmer C; Bondonno CP; Bondonno NP; Devine A; Ward NC; Byrnes E; Schultz CJ; Woodman R; Croft K; Hodgson JM; Blekkenhorst LC
    Bone Rep; 2020 Jun; 12():100274. PubMed ID: 32455149
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparison of the effects of alendronate and risedronate on bone mineral density and bone turnover markers in postmenopausal osteoporosis.
    Sarioglu M; Tuzun C; Unlu Z; Tikiz C; Taneli F; Uyanik BS
    Rheumatol Int; 2006 Jan; 26(3):195-200. PubMed ID: 15580349
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prevention of hip fractures by exposure to sunlight and pharmacotherapy in patients with Alzheimer's disease.
    Iwamoto J; Sato Y; Tanaka K; Takeda T; Matsumoto H
    Aging Clin Exp Res; 2009; 21(4-5):277-81. PubMed ID: 19959915
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of risedronate in osteoporotic HIV males, according to gonadal status: a pilot study.
    Pepe J; Isidori AM; Falciano M; Iaiani G; Salotti A; Diacinti D; Del Fiacco R; Sbardella E; Cipriani C; Piemonte S; Raimo O; Biondi P; Biamonte F; Lenzi A; Minisola S
    Endocrine; 2014 Nov; 47(2):456-62. PubMed ID: 25104272
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of calcium fortified milk supplementation with or without vitamin K on biochemical markers of bone turnover in premenopausal women.
    Kruger MC; Booth CL; Coad J; Schollum LM; Kuhn-Sherlock B; Shearer MJ
    Nutrition; 2006; 22(11-12):1120-8. PubMed ID: 17030114
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Risedronate, an effective treatment for glucocorticoid-induced bone loss in CKD patients with or without concomitant active vitamin D (PRIUS-CKD).
    Fujii N; Hamano T; Mikami S; Nagasawa Y; Isaka Y; Moriyama T; Horio M; Imai E; Hori M; Ito T
    Nephrol Dial Transplant; 2007 Jun; 22(6):1601-7. PubMed ID: 17124283
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Regulation of mineral-to-matrix ratio of lumbar trabecular bone in ovariectomized rats treated with risedronate in combination with or without vitamin K2.
    Otomo H; Sakai A; Ikeda S; Tanaka S; Ito M; Phipps RJ; Nakamura T
    J Bone Miner Metab; 2004; 22(5):404-14. PubMed ID: 15316861
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Association of serum undercarboxylated osteocalcin with serum estradiol in pre-, peri- and early post-menopausal women.
    Yasui T; Uemura H; Tomita J; Miyatani Y; Yamada M; Miura M; Irahara M
    J Endocrinol Invest; 2006 Nov; 29(10):913-8. PubMed ID: 17185901
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of risedronate on bone turnover markers in osteoporotic postmenopausal women: comparison of two protocols of treatment.
    Bahlous A; Bouzid K; Sahli H; Sallami S; Abdelmoula J
    Tunis Med; 2009 Jun; 87(6):380-1. PubMed ID: 19927782
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Post-menopausal women with rheumatoid arthritis who are treated with raloxifene or alendronate or glucocorticoids have lower serum undercarboxylated osteocalcin levels.
    Mokuda S; Okuda Y; Onishi M; Sawada N; Matoba K; Yamada A; Jouyama K; Takasugi K
    J Endocrinol Invest; 2012 Jul; 35(7):661-4. PubMed ID: 21970822
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Short-term menatetrenone therapy increases gamma-carboxylation of osteocalcin with a moderate increase of bone turnover in postmenopausal osteoporosis: a randomized prospective study.
    Shiraki M; Itabashi A
    J Bone Miner Metab; 2009; 27(3):333-40. PubMed ID: 19172219
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evaluation of weekly risedronate treatment in postmenopausal women with osteoprotegerin.
    Gulseren A; Peyman B; Pinar A
    Panminerva Med; 2011 Jun; 53(2):75-80. PubMed ID: 21659972
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The Intriguing Correlation between Undercarboxylated Osteocalcin and Vitamin D.
    Buranasinsup S; Bunyaratavej N
    J Med Assoc Thai; 2015 Sep; 98 Suppl 8():S16-20. PubMed ID: 26529809
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Inverse correlation between the changes of lumbar bone mineral density and serum undercarboxylated osteocalcin after vitamin K2 (menatetrenone) treatment in children treated with glucocorticoid and alfacalcidol.
    Inoue T; Sugiyama T; Matsubara T; Kawai S; Furukawa S
    Endocr J; 2001 Feb; 48(1):11-8. PubMed ID: 11403096
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Vitamin K status of healthy Japanese women: age-related vitamin K requirement for gamma-carboxylation of osteocalcin.
    Tsugawa N; Shiraki M; Suhara Y; Kamao M; Tanaka K; Okano T
    Am J Clin Nutr; 2006 Feb; 83(2):380-6. PubMed ID: 16469998
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Change in serum undercarboxylated osteocalcin concentration in bilaterally oophorectomized women.
    Yasui T; Uemura H; Tomita J; Miyatani Y; Yamada M; Kuwahara A; Matsuzaki T; Maegawa M; Miura M; Irahara M
    Maturitas; 2007 Mar; 56(3):288-96. PubMed ID: 17030103
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Vitamin K supplementation reduces serum concentrations of under-gamma-carboxylated osteocalcin in healthy young and elderly adults.
    Binkley NC; Krueger DC; Engelke JA; Foley AL; Suttie JW
    Am J Clin Nutr; 2000 Dec; 72(6):1523-8. PubMed ID: 11101481
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparison of concurrent treatment with vitamin K
    Tanaka S; Miyazaki T; Uemura Y; Miyakawa N; Gorai I; Nakamura T; Fukunaga M; Ohashi Y; Ohta H; Mori S; Hagino H; Hosoi T; Sugimoto T; Itoi E; Orimo H; Shiraki M
    J Bone Miner Metab; 2017 Jul; 35(4):385-395. PubMed ID: 27484436
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of vitamin K(2) and risedronate on bone formation and resorption, osteocyte lacunar system, and porosity in the cortical bone of glucocorticoid-treated rats.
    Iwamoto J; Matsumoto H; Takeda T; Sato Y; Liu X; Yeh JK
    Calcif Tissue Int; 2008 Aug; 83(2):121-8. PubMed ID: 18543014
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.